ProFound Insights, ProFound Impacts: Webinar Registration

Discover the power of ProFound AI^® Risk, the latest addition to iCAD’s breast AI suite and the world’s first clinical decision support tool that provides an accurate, short-term breast cancer risk estimation that is truly personalized for each woman, based only on her mammogram.

Join us on June 21 at 10 am PT/1 pm ET/7 pm CEST as we sit down with leading experts who will discuss the significant impact of ProFound AI Risk, including distinguished researchers from the Karolinska Institutet and clinicians who are using it in daily practice.

Learn how only iCAD’s breast AI suite offers a single, triple-threat solution for cancer detection, density assessment and risk evaluation that provides a more holistic approach to personalized screening and superior cancer detection.

Axel Gräwingholt, MD

Radiologie am Theater, Paderborn, Germany

Mark Traill, MD

University of Michigan Health-West, Wyoming, MI

Mikael Eriksson, PhD

Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden

Per Hall, MD, PhD

Professor/Senior Physician, Karolinska Institutet and Södersjukhuset, Stockholm, Sweden

Register for Webinar

First Name:

Last Name:

Company:

Email:

Phone:

Country:

State:

Person Source:

Lead Source Detail:

Most Recent Lead Source:

Most Recent Lead Source Detail:

UTM Campaign:

UTM Medium:

UTM Source:

Most Recent UTM Campaign:

Most Recent UTM Medium:

Most Recent UTM Source: